Rejection Sensitivity clinical trials

Explore recruiting rejection sensitivity clinical trials.

Recruiting rejection sensitivity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rejection Sensitivity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Psilocybin in alcohol use disorder with comorbid depression - Randomized double-blind controlled pilot study.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Rejection Sensitivity trials by city

Rejection Sensitivity in Toronto Rejection Sensitivity in Vancouver Rejection Sensitivity in Montreal Rejection Sensitivity in Calgary Rejection Sensitivity in Edmonton Rejection Sensitivity in Ottawa Rejection Sensitivity in Winnipeg Rejection Sensitivity in Quebec City Rejection Sensitivity in Hamilton Rejection Sensitivity in Kitchener Rejection Sensitivity in London Rejection Sensitivity in Halifax Rejection Sensitivity in New York Rejection Sensitivity in Los Angeles Rejection Sensitivity in Chicago Rejection Sensitivity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease